Overall, among other findings, the discipline raises several possible antitrust concerns and a number of potential efficiency explanations involving the conduct of pharmaceutical companies.
* legislative mandates and the application of information technology have transformed this industry in ways that have shifted the focus away from non- charge forms of ambition (e.g., competition for the allegiance of physicians) toward forms of price competition (e.g., competition for HMO contracts and preferred drug formulary placements). Along with describing these new forms of competition, the report raises the possibility that information technology networks might assist price coordination among pharmaceutical companies.
* Industry transformations raise the possibility of anticompetitive forms of price difference in drug markets that are difficult to enter and in situations where doctors and patients have few alternative therapies. Price differences in these markets, however, whitethorn also be consistent with competitive forms of price discrimination.
* MFN furnish in vertical contracts between drug companies and PBMs may facilitate price coordination in either upstream prescription drug or downstream PBM service markets by making it pricey for firms to engage in selective price cutting, or by raising competitor costs in other ways. These supply are also the same as those...If you want to give rise a full essay, order it on our website: Orderessay
If you want to get a full essay, wisit our page: write my essay .
No comments:
Post a Comment